In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease.


Autoria(s): Himmelrich H.; Launois P.; Maillard I.; Biedermann T.; Tacchini-Cottier F.; Locksley R.M.; Röcken M.; Louis J.A.
Data(s)

2000

Resumo

In contrast to intact BALB/c mice, BALB/c mice rendered deficient in Vbeta4+ CD4+ T cells develop a Th1 response to infection with Leishmania major and are resistant. Vbeta4-deficient BALB/c mice are unable to generate the early IL-4 transcription occurring in Vbeta4 Valpha8 CD4+ T cells of BALB/c mice within 1 day of infection. Here we demonstrate that treatment of Vbeta4-deficient BALB/c mice with IL-4 during the first 64 h after infection instructs Th2 cell development and susceptibility to infection. The demonstrated inability of IL-4 to reverse the resistant phenotype of BALB/c mice treated with anti-CD4 mAb the day before infection suggest that these effects of IL-4 require its interaction with CD4+ T cells. In contrast to draining lymph node cells from BALB/c mice, cells from Vbeta4-deficient BALB/c mice remain responsive to IL-12 following infection. Strikingly, administration of IL-4 to Vbeta4-deficient BALB/c mice renders their lymph node cells unresponsive to IL-12 by down-regulating IL-12R beta2-chain expression. This study directly demonstrates that in BALB/c mice IL-4 is necessary and sufficient to initiate the molecular events steering Th2 cell maturation and susceptibility to L. major.

Identificador

http://serval.unil.ch/?id=serval:BIB_BD95C394475C

isbn:0022-1767 (Print)

pmid:10779790

isiid:000086624300050

Idioma(s)

en

Fonte

Journal of Immunology, vol. 164, no. 9, pp. 4819-4825

Palavras-Chave #Animals; CD4-Positive T-Lymphocytes/metabolism; CD4-Positive T-Lymphocytes/pathology; Cell Differentiation/genetics; Cell Differentiation/immunology; Disease Progression; Down-Regulation/immunology; Female; Immune Tolerance/genetics; Immunity, Innate/genetics; Injections, Intraperitoneal; Interleukin-12/metabolism; Interleukin-12/pharmacology; Interleukin-4/administration & dosage; Interleukin-4/biosynthesis; Leishmania major/immunology; Leishmaniasis, Cutaneous/genetics; Leishmaniasis, Cutaneous/immunology; Lymph Nodes/cytology; Lymph Nodes/immunology; Lymphopenia/genetics; Lymphopenia/immunology; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Receptors, Antigen, T-Cell, alpha-beta/genetics; Receptors, Interleukin/antagonists & inhibitors; Receptors, Interleukin/biosynthesis; Receptors, Interleukin-12; Th2 Cells/immunology; Th2 Cells/metabolism
Tipo

info:eu-repo/semantics/article

article